Special Issue

Topic: Precision Targeting and Blood-Brain Barrier Penetration of Extracellular Vesicles

A Special Issue of Extracellular Vesicles and Circulating Nucleic Acids

ISSN 2767-6641 (Online)

Submission deadline: 31 Oct 2024

Guest Editor(s)

Xian Shuang Liu
Associate Scientist/Associate Professor, Department of Neurology, Henry Ford Health; Department of Physiology, College of Human Medicine, Michigan State University, Michigan, MI, USA.

Special Issue Introduction

Precision targeting includes the development of delivery systems that specifically target desired cells or tissues, minimizing off-target effects and improving the overall efficacy of therapeutic interventions. This approach often utilizes various targeting ligands or surface modifications to guide drug-loaded vesicles to their intended destination with high specificity. The blood-brain barrier (BBB) is a highly selective barrier that protects the brain from circulating toxins and pathogens but poses a challenge for drug delivery to the central nervous system (CNS). Overcoming the BBB is crucial for the therapy of neurological diseases. Extracellular vesicles (EVs), such as exosomes, have gained attention as potential carriers for drug delivery due to their natural ability to transport cargo between cells. Strategies to enhance BBB penetration involve optimizing the properties of EVs or incorporating specific modifications that facilitate their transport across the BBB. Precision targeting and BBB penetration in the context of EVs will provide promising avenues for the development of more effective and targeted therapies, particularly in the area of neurodegenerative disorders and other diseases affecting the CNS.

1. Neurological Disorders and Treatment: Examine specific neurological disorders such as Alzheimer's disease, Parkinson's disease, brain tumors, stroke, traumatic brain injury, Encephalitis, etc., and explore how precision targeting and BBB penetration strategies can be tailored for effective therapeutic interventions.
2. Nanotechnology in Drug Delivery: Delve into the nanotechnological aspects of drug delivery, highlighting nanoparticles, liposomes, and other nanocarriers that can aid in overcoming biological barriers, such as the BBB, for precise drug delivery.
3. Molecular Engineering for EVs: Explore the molecular modifications and engineering techniques applied to EVs to improve their stability, cargo-loading capacity, and ability to traverse biological barriers, especially the BBB.
4. Blood-Brain Barrier Challenges: Discuss the unique challenges posed by the BBB in drug delivery and how these challenges impact the treatment of neurological disorders.
5. Targeted Drug Delivery Systems: Explore various strategies for precision targeting, including ligand-based approaches, antibody targeting, and other surface modifications, to enhance the specificity of drug-loaded vesicles.
6. Clinical Applications and Trials: Review current and potential clinical applications of precision-targeted drug delivery systems using EVs, including ongoing trials and research advancements.
7. Biomarkers for Precision Targeting: Discuss the identification and utilization of biomarkers that can aid in the precision targeting of EVs to specific cells or tissues.
8. Biological Barriers Beyond the BBB: Consider other biological barriers, such as the blood-cerebrospinal fluid barrier, and strategies to overcome these barriers for improved drug delivery.
9. Ethical and Safety Considerations: Address ethical considerations and safety aspects related to the use of precision-targeted drug delivery systems, particularly when applied to the CNS.


Extracellular vesicles, exosomes, drug delivery, blood-brain barrier, neurological disorders, nanoparticles, nanotechnology, molecular engineering, precision medicine, biomarkers

Submission Deadline

31 Oct 2024

Submission Information

For Author Instructions, please refer to https://www.oaepublish.com/evcna/author_instructions
For Online Submission, please login at https://oaemesas.com/login?JournalId=evcna&SpecialIssueId=evcna240118
Submission Deadline: 31 Oct 2024
Contacts: Inga Ren, Assistant Editor, EVCNA-editor@oaemesas.com

Published Articles

Coming soon
Extracellular Vesicles and Circulating Nucleic Acids
ISSN 2767-6641 (Online)
Follow Us


All published articles are preserved here permanently:



All published articles are preserved here permanently: